FREE SHIPPING ON ORDERS OVER $150

glp-1 receptor agonists in idiopathic intracranial hypertension Significantly Improve Effects of Efficacy of glucagon-like peptide-1 receptor

$27.20

Quantity
- +
Description

PMID: 36870274

glp-1 receptor agonists in idiopathic intracranial hypertension Significantly Improve Effects of Efficacy of glucagon-like peptide-1 receptor

has developed an algorithm for the management of obesity in primary care with accompanying resources for MGP publishing, which were supported by arms length sponsorship from Novo Nordisk (honoraria received)

glp-1 receptor agonists in idiopathic intracranial hypertension Significantly Improve Effects of Efficacy of glucagon-like peptide-1 receptor

10.1016/j.metabol.2016.03.009 Metabolism 25 FontanellaR.GhoshP.PesapaneA.TaktazF.PuocciA.FranzeseM.et al (2024)

glp-1 receptor agonists in idiopathic intracranial hypertension Significantly Improve Effects of Efficacy of glucagon-like peptide-1 receptor

Several additional GLP-1 receptor agonists also display neuroprotective properties in preclinical AD models

glp-1 receptor agonists in idiopathic intracranial hypertension Significantly Improve Effects of Efficacy of glucagon-like peptide-1 receptor

Moulton CD, Pickup JC, Amiel SA, Winkley K, Ismail K

glp-1 receptor agonists in idiopathic intracranial hypertension Significantly Improve Effects of Efficacy of glucagon-like peptide-1 receptor

Emerging preclinical evidence suggests GLP-1 may influence neuronal survival, synaptic plasticity, and neuroinflammationprocesses that are disrupted in neurodegenerative conditions

glp-1 receptor agonists in idiopathic intracranial hypertension Significantly Improve Effects of Efficacy of glucagon-like peptide-1 receptor

You may also like

recommand products